Pleuropneumonia

01/01/2013 - "A better understanding of how T1 vaccination confers immunity would facilitate the rational design of improved vaccines against contagious bovine pleuropneumonia (CBPP). "
06/01/2004 - "To evaluate the efficacy of two new-generation porcine pleuropneumonia vaccines when challenged with Australian isolates of Actinobacillus pleuropneumoniae of serovars 1 and 15. "
01/01/2015 - "Mathematical modelling of the transmission dynamics of contagious bovine pleuropneumonia reveals minimal target profiles for improved vaccines and diagnostic assays."
01/15/2013 - "Thus the present study is expected to contribute to the development of a live oral vaccine against porcine pleuropneumonia as an alternative to current conventional vaccines."
03/12/1999 - "No other association was significant, and no evidence of synergy between the vaccines in influencing lesion severity for pleuropneumonia was detected (within the limitations set by the trial design)."

03/01/2014 - "In this study, the Actinobacillus pleuropneumoniae antigens ApxIA, ApxIIA, ApxIIIA and OmpA were expressed in an attenuated strain of Salmonella (∆lon∆cpxR∆asd) for prevention of porcine pleuropneumonia. "
01/01/1965 - "II. FURTHER STUDIES ON THE PRECIPITATING ANTIGENS IN THE BODY FLUIDS FROM CASES OF CONTAGIOUS BOVINE PLEUROPNEUMONIA."
03/01/2014 - "Optimization of immune strategy for a construct of Salmonella-delivered ApxIA, ApxIIA, ApxIIIA and OmpA antigens of Actinobacillus pleuropneumoniae for prevention of porcine pleuropneumonia using a murine model."
07/01/1999 - "For the surveillance of pig herds infected with porcine pleuropneumonia, an enzyme-linked immunosorbent assay (ELISA) using the recombinant Actinobacillus pleuropneumoniae ApxII protein as species- but not serotype-specific antigen was developed. "
07/01/1999 - "A novel enzyme-linked immunosorbent assay using the recombinant Actinobacillus pleuropneumoniae ApxII antigen for diagnosis of pleuropneumonia in pig herds."

03/01/1968 - "Preliminary studies on living culture and inactivated vaccines against contagious bovine pleuropneumonia."
10/01/1986 - "Observations on experimental inactivated vaccines for contagious bovine pleuropneumonia."
10/01/1986 - "In two trials the efficacy of inactivated vaccines against contagious bovine pleuropneumonia was tested by exposing vaccinated cattle to droplet infection provided by close contact with experimentally infected 'donors'. "

01/06/2010 - "suis shares many virulence factors in common with Actinobacillus pleuropneumoniae and can cause a haemorrhagic pleuropneumonia similar to that caused by A. "
10/01/2009 - "Apx toxins have been identified as important virulence factors of Actinobacillus pleuropneumoniae, the etiologic agent of porcine pleuropneumonia. "
07/01/2009 - "Actinobacillus pleuropneumoniae, the causative agent of porcine pleuropneumonia, produces Apx toxins that are recognized as major virulence factors. "
01/01/2008 - "Actinobacillus pleuropneumoniae, the causative bacterial agent of porcine pleuropneumonia, produces Apx toxins which belong to RTX toxin family and are recognized as the major virulence factors. "
11/01/1992 - "In an attempt to protect pigs against swine pleuropneumonia induced by Actinobacillus pleuropneumoniae (SPAP) by neutralizing the effects of three virulence factors of A. "

04/01/1995 - "The efficacy of florfenicol was evaluated on experimental Actinobacillus pleuropneumonia in 5 to 7-week-old pigs. "
04/01/1995 - "Efficacy of florfenicol on experimental Actinobacillus pleuropneumonia in pigs."
10/01/2002 - "Tissue pharmacokinetic data could be evidence for regime designing of florfenicol in treatment of porcine pleuropneumonia."
01/01/2000 - "Development of pleuropneumonia was prevented in all the pigs medicated with 40 ppm of florfenicol. "
01/01/2000 - "Postmortem examination revealed severe pleuropneumonia in pigs from the control group and pneumonic lesions in 40% of the animals treated with 20 ppm of florfenicol. "

06/01/2004 - "Comparison of the efficacy of a subunit and a live streptomycin-dependent porcine pleuropneumonia vaccine."
02/01/1982 - "A 2nd isolate of H pleuropneumoniae, SD-2, recovered from a pig in a different outbreak of porcine pleuropneumonia, was resistant to streptomycin and sulfadiazine. "
12/01/2004 - "An evaluation of the role of antibodies to Actinobacillus pleuropneumoniae serovar 1 and 15 in the protection provided by sub-unit and live streptomycin-dependent pleuropneumonia vaccines."

02/01/1992 - "Passive transfer of immune swine serum resulted in protection against pleuropneumonia and in levels of specific serum IgG which were similar to those in actively immunized pigs. "
02/01/1992 - "It is concluded that specific serum IgG antibodies are important in protection from porcine pleuropneumonia."
07/01/1996 - "This boy with a history of frequent but not severe respiratory tract infections was referred to hospital because of severe pleuropneumonia and decreased levels of IgA (0.23 g/L), but normal IgG and IgM levels. "
04/01/1992 - "The paper deals with 8 cases of different forms of bacterial respiratory infections (bronchiectasis, pleuropneumonia, tuberculosis), in which humoral immune deficits were noted: 2 dysgammaglobulinemia with IgA absence, 3 hypogammaglobulinemia with IgG deficit as well as IgA and IgM absence, 2 hypogammaglobulinemia with IgG and IgM deficit and IgA absence, and 1 hypogammaglobulinemia with IgA absence and IgM deficit. "

09/01/2006 - "Our results thus demonstrated that IgA is produced locally in MmmSC experimentally infected cattle by contact and may play a role in protection against contagious bovine pleuropneumonia."
07/01/1996 - "This boy with a history of frequent but not severe respiratory tract infections was referred to hospital because of severe pleuropneumonia and decreased levels of IgA (0.23 g/L), but normal IgG and IgM levels. "
04/01/1992 - "The paper deals with 8 cases of different forms of bacterial respiratory infections (bronchiectasis, pleuropneumonia, tuberculosis), in which humoral immune deficits were noted: 2 dysgammaglobulinemia with IgA absence, 3 hypogammaglobulinemia with IgG deficit as well as IgA and IgM absence, 2 hypogammaglobulinemia with IgG and IgM deficit and IgA absence, and 1 hypogammaglobulinemia with IgA absence and IgM deficit. "

10/01/2006 - "The efficacy of danofloxacin (Advocin A180) was evaluated for the treatment of contagious caprine pleuropneumonia (CCPP) caused by Mycoplasma capricolum subsp. "
12/01/2006 - "Danofloxacin (Advocin) reduces the spread of contagious bovine pleuropneumonia to healthy in-contact cattle."
10/01/2006 - "Effect of danofloxacin (Advocin A180) on goats affected with contagious caprine pleuropneumonia."
02/26/2000 - "Minimum inhibitory concentrations (MIC) and minimum mycoplasmacidal concentrations (MMC) of the antimicrobials danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin were determined in vitro for 20 isolates of Mycoplasma mycoides subspecies mycoides small colony type (MmmSC), the causative agent of contagious bovine pleuropneumonia (CBPP). "

06/23/1962 - "[Pyocyanic pleuropneumonia appearing in the course of typhoid fever treated with chloramphenicol and cortsonic agents]."
08/15/1988 - "An important reduction in the in vitro efficacy of spectinomycin and chloramphenicol was recorded between 1981 and 1986 against the causal agent of porcine pleuropneumonia Actinobacillus. "

09/01/2012 - "Combination fibrinolytic therapy in the treatment of chronic septic pleuropneumonia in a Thoroughbred gelding."
05/02/2009 - "Intrapleural fibrinolytic therapy in the management of septic pleuropneumonia in a horse."

10/01/1995 - "When treated with high doses of atropine (0.25 mg per kg) and/or xylocaine spray using a bronchoscope, which suppressed mucus secretion and ciliary activity, the pigs showed severe pleuropneumonia and 2 treated pigs died within 36 hr after inoculating 320 colony forming units (CFU)/2ml of App serotype 1. Histopathologically, their lungs had alveolar and interlobular edema and intravascular fibrinous thrombosis. "

04/01/2006 - "Severe tracheal lesions and pleuropneumonia have not been reported as sequela of equine myelography, and should be considered as possible complications following repeated cervical manipulation during myelography in the horse."

10/01/2010 - "Standing lateral thoracotomy should be considered for the treatment of complicated pleuropneumonia in horses."

07/01/2005 - "The authors describe a 4-year-old girl with acute lymphoblastic leukemia complicated with pleuropneumonia caused by an Absidia infection during the induction of remission. "